Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-02-22
2005-02-22
Solola, Taofiq (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S457000, C549S404000
Reexamination Certificate
active
06858645
ABSTRACT:
A new salt (R)-3-N,N-dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide hydrogen tartrate, particularly the (2R,3R)-tartrate thereof, most particularly the (R)-3-N,N-dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide hydrogen (2R,3R)-tartrate monohydrate, processes for the manufacture of said tartrate salt, the use of the salt in medicine, the use of the tartrate salt in the manufacture of pharmaceutical formulations, and a method for the treatment of CNS disorders by administration of the tartrate salt to a host in need of such treatment.
REFERENCES:
patent: 5616610 (1997-04-01), Evenden et al.
patent: 5990114 (1999-11-01), Leonardi et al.
patent: 9511891 (1995-05-01), None
patent: 9731637 (1997-09-01), None
Nyqvist Hakan
Sohn Daniel D
AstraZeneca AB
Solola Taofiq
White & Case LLP
LandOfFree
Tartrate salts of (R) -3-N,N-... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tartrate salts of (R) -3-N,N-..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tartrate salts of (R) -3-N,N-... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3497016